IP Library Granted Patent US 9,931,433
Granted Patent B2
US 9,931,433 · App. 15/520,603 · Granted Apr 3, 2018

Time-controlled glucose releasing hydrogels and applications thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,433
App. No.
15/520,603
Granted
Apr 3, 2018
Kind
B2
Abstract

The present invention relates generally to a hydrogel releasing glucose in a time-controlled manner, to medical applications thereof, and to a method for preparing said hydrogel.

Claims (45)

1. A time-controlled glucose releasing hydrogel, comprising:

a) a water-containing gelified polymer;

b) a glucose polymer entrapped in polymer a); and

c) at least one enzyme capable of hydrolyzing the glucose polymer b) into glucose, said enzyme being entrapped in polymer a).

2. The hydrogel according to claim 1 , wherein said polymer a) is a protein polymer selected from the group consisting of water-containing gelified silk proteins, soy proteins, milk proteins, wheat proteins, linen proteins, egg proteins, albumin, elastin, myosin, actin, myoglobin, polylysine, polyglutamine, self-assembling peptides, proteins comprising RGD sequence(s), and derivatives thereof.

3. The hydrogel according to claim 2 , wherein said protein comprising RGD sequence(s) is fibrin.

4. The hydrogel according to claim 3 , wherein the concentration of fibrin is ranging from about 2.5 mg/ml to about 90 mg/ml.

5. The hydrogel according to claim 1 , wherein said polymer a) is a synthetic polymer selected from the group consisting of water-containing gelified polyethylene oxide (PEO), polyacrylic acid (PAA), polypropylene oxide (PPO), polyethyl hydroxide (PEH), polyvinyl alcohol (PVA), N-isopropylacrylamide (NIPAM), polyacrylamide (PAM), polyvinyl sulfone (PVS), and derivatives thereof.

6. The hydrogel according to claim 1 , wherein said glucose polymer b) is selected from the group consisting of starch, amylose, amylopectin, glycogen, maltodextrins, cyclodextrins polymers, isomaltose polymers, icodextrins, malto-oligosaccharides, dextran, cellulose, and derivatives thereof.

7. The hydrogel according to claim 6 , wherein said glucose polymer is starch.

8. The hydrogel according to claim 7 , wherein the concentration of starch is ranging from about 1% (w/v) to about 10% (w/v).

9. The hydrogel according to claim 1 , wherein said enzyme is selected from the group consisting of α-glucosidases, β-glucosidases, dextrinases, maltodextrinases, α-amylases, β-amylases, maltohydrolases, cellobiosidases, and combinations thereof.

10. The hydrogel according to claim 1 , wherein said enzyme is entrapped within polymeric particles in polymer a).

11. The hydrogel according to claim 10 , wherein said polymeric particles are nanoparticles.

12. The hydrogel according to claim 10 , wherein said polymeric particles are selected from the group consisting of alginate, chitin, gelatin, collagen, albumin, poly(lactic) acid (PLA), poly(glycolic) acid (PGA), poly(lactic-co-glycolic) acid (PLGA), polyhydroxybutyrate (PHB), poly(hy-d roxybutyrate-co-valerate) (PHBV), polycaprolactone (PCL), poly(methyl methacrylate) (PMMA), poly(cyanoacrylate) (PCA) polymeric particles, and derivatives thereof.

13. The hydrogel according to claim 1 , further comprising at least one biological material, said material being entrapped in said hydrogel.

14. The hydrogel according to claim 13 , wherein said biological material is selected from the group consisting of cells, tissues, stromata, derivatives thereof, and combinations thereof.

15. A medical device, comprising the hydrogel as defined in claim 1 .

16. The device according to claim 15 , wherein said device is selected from the group consisting of a patch, a bandage, and an implant.

17. A method for treating a disorder in a subject in need thereof, comprising:

(i) administering to said subject a time-controlled glucose releasing hydrogel, comprising:

a) a water-containing gelified polymer;

b) a glucose polymer entrapped in polymer a); and

c) at least one enzyme capable of hydrolyzing the glucose polymer b) into glucose, said enzyme being entrapped in polymer a); or

(ii) using on said subject a medical device comprising a time-controlled glucose releasing hydrogel, comprising:

d) a water-containing gelified polymer;

e) a glucose polymer entrapped in polymer d); and

f) at least one enzyme capable of hydrolyzing the glucose polymer e) into glucose, said enzyme being entrapped in polymer d).

18. A method of tissue regeneration in a subject in need thereof, comprising:

(i) administering to said subject a time-controlled glucose releasing hydrogel, comprising:

a) a water-containing gelified polymer;

b) a glucose polymer entrapped in polymer a); and

c) at least one enzyme capable of hydrolyzing the glucose polymer b) into glucose, said enzyme being entrapped in polymer a); or

(ii) using on said subject a medical device comprising a time-controlled glucose releasing hydrogel, comprising:

d) a water-containing gelified polymer;

e) a glucose polymer entrapped in polymer d); and

f) at least one enzyme capable of hydrolyzing the glucose polymer e) into glucose, said enzyme being entrapped in polymer d).

19. A method for preparing the hydrogel as defined in claim 1 , comprising the step of mixing:

a) a water-soluble gellable monomer or polymer;

b) a glucose polymer; and

c) at least one enzyme capable of hydrolyzing the glucose polymer b) into glucose.

20. A kit, comprising:

d) a water-soluble gellable monomer or polymer;

e) a glucose polymer; and

f) at least one enzyme capable of hydrolyzing the glucose polymer b) into glucose.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060541 FRAME: 0336. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 062387/0346 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060390 FRAME: 0122. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →
CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
MERGER AND CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE DE PARIS
To: UNIVERSITE DE PARIS
Reel/Frame 060541/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2018
From: DESCHEPPER, MICKAEL; PETITE, HERVÉ; LOGEART AVRAMOGLOU, DELPINE; PAQUET, JOSEPH; PAUTHE, EMMANUEL; BIDAULT, LAUREN; LARRETA GARDE, VÉRONIQUE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE PARIS DIDEROT PARIS 7; UNIVERSITE CERGY-PONTOISE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Reel/Frame 044965/0356 →